hotspot -WSS

hotspot

author：Wikipedia 2025-08-21 10:38:01 - browse：3

When Prozac first entered the psychiatry scene in in the late ’80s, the profession was still Freud’s territory. Many considered taking medication to treat depression a failure. But that was all about to change, as early stewards like psychiatrist Peter Kramer refused to shy away from the new drug’s potential. These days, he says that people take for granted all of the progress that’s been made with antidepressant treatment in the past three decades.

“If you were going to be depressed any time in history and were interested in having an effective treatment, you would want to be alive now. But we’ve lost our wonderment about that,” said Kramer, the author of the groundbreaking 1993 book “Listening to Prozac.”

This week, Kramer joins me to discuss how the country’s relationship with antidepressants has changed since the publication of his book three decades ago. The conversation is based on his First Opinion, “What antidepressants are saying 30 years after the publication of ‘Listening to Prozac.’”

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts. And don’t forget to sign up for the First Opinion newsletter to read each week’s best First Opinion essays.

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Drastic changes should bring profitability, startup health insurers say

WSS

Hepatitis C has a cure — but many Americans still lack access to it

Wayne Brady comes out as pansexual: 'Free to love whomever I want'

A biotech analyst on neuroscience, placebo effect, not over

Police still searching for prisoner who escaped from NYC hospital

Supreme Court strikes down use of affirmative action

Bright Health sells Medicare Advantage business to Molina

focus

hotspot

Wikipedia

Malaria cases in Florida and Texas: Here’s what you need to know

NIH trials fail to test meaningful long Covid therapies, experts say

What does generative AI mean for health care? We asked experts

Tori Bowie and the unacceptable rates of Black maternal death

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

A biotech analyst on neuroscience, placebo effect, not over

How to save PrEP access — and even expand it

Drastic changes should bring profitability, startup health insurers say

DIEP, the 'gold standard' of breast reconstruction, is under threat

Medicare proposal to cover medical devices draws a mixed reaction

focus

Psychedelics group wrestles with new pharma identity

Listen: Merck v. USA, the best of ASCO, and Leqembi at the FDA

Methadone doses haven’t kept up in the age of fentanyl

23andMe had bad news about my health. I wish a person had delivered it

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

In Memoriam: Notable people who died in 2023

Wikipedia

focus

Wikipedia

explore